Number of the records: 1  

Novel nanoparticle delivery systems for rifampicin: an effective strategy against tuberculosis?

  1. 1.
    SYSNO ASEP0475342
    Document TypeJ - Journal Article
    R&D Document TypeO - Ostatní
    Subsidiary JČlánek ve WOS
    TitleNovel nanoparticle delivery systems for rifampicin: an effective strategy against tuberculosis?
    Author(s) Trousil, Jiří (UMCH-V) RID, ORCID
    Hrubý, Martin (UMCH-V) RID, ORCID
    Source TitleNanomedicine. - : Future Medicine - ISSN 1743-5889
    Roč. 12, č. 12 (2017), s. 1359-1361
    Number of pages3 s.
    Languageeng - English
    CountryGB - United Kingdom
    Keywordsnanoparticles ; rifampicin ; tuberculosis
    Subject RIVCD - Macromolecular Chemistry
    OECD categoryPolymer science
    R&D ProjectsLO1507 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Method of publishingLimited access
    Institutional supportUMCH-V - RVO:61389013
    UT WOS000403575000002
    EID SCOPUS85020930556
    DOI10.2217/nnm-2017-0117
    AnnotationTuberculosis (TB) is a highly infectious disease caused by Mycobacterium tuberculosis. Approximately, a third of the world’s population is infected with M. tuberculosis, resulting in a global health problem. Although potentially curative treatments have been available for approximately 50 years, TB remains the leading cause of preventable death in the world.
    WorkplaceInstitute of Macromolecular Chemistry
    ContactEva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358
    Year of Publishing2018
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.